- Clinical Efforts to Combine Endocrine Agents with Targeted Therapies against Epidermal Growth Factor Receptor/Human Epidermal Growth Factor Receptor 2 and Mammalian Target of Rapamycin in Breast Cancer
Stephen R.D. Johnston, 2006, Clinical Cancer Research CrossRef - Nonendocrine Pathways and Endocrine Resistance
Robert I. Nicholson et al, 2004, Clinical Cancer Research CrossRef - Cross-Talk between Estrogen Receptor and Growth Factor Pathways as a Molecular Target for Overcoming Endocrine Resistance
Rachel Schiff et al, 2004, Clinical Cancer Research CrossRef - Tamoxifen resistance and Her2/neu expression in an aged, irradiated rat breast carcinoma model
Norman C. Peterson et al, 2005, Carcinogenesis CrossRef - Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer
C.Kent Osborne et al, 2003, The Breast CrossRef - Combinations of Endocrine and Biological Agents: Present Status of Therapeutic and Presurgical Investigations
Stephen RD Johnston, 2005, Clinical Cancer Research CrossRef